Sandra L. Kuentzel
About
In The Last Decade
Sandra L. Kuentzel
25 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 104
- Molecular Biology 745
- Organic Chemistry 289
- Pharmacology 240
- Oncology 205
- Biotechnology 175
Countries citing papers authored by Sandra L. Kuentzel
This map shows the geographic impact of Sandra L. Kuentzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra L. Kuentzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra L. Kuentzel more than expected).
Fields of papers citing papers by Sandra L. Kuentzel
This network shows the impact of papers produced by Sandra L. Kuentzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra L. Kuentzel. The network helps show where Sandra L. Kuentzel may publish in the future.
Co-authorship network of co-authors of Sandra L. Kuentzel
This figure shows the co-authorship network connecting the top 25 collaborators of Sandra L. Kuentzel. A scholar is included among the top collaborators of Sandra L. Kuentzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra L. Kuentzel. Sandra L. Kuentzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 135 | |
| 4 | 23 | |
| 5 | 72 | |
| 6 | 49 | |
| 7 | 2 | |
| 8 | Biochemical and cellular effects of didemnins A and B. | 63 |
| 9 | 52 | |
| 10 | Comparative biological and biochemical effects of nogalamycin and its analogs on L1210 leukemia. | 52 |
| 11 | 13 | |
| 12 | 229 | |
| 13 | 49 | |
| 14 | 13 | |
| 15 | 14 | |
| 16 | Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice. | 20 |
| 17 | Cell-kill kinetics of several S-phase-specific drugs. | 84 |
| 18 | 1 | |
| 19 | A microbiological assay for cyclocytidine--disposition studies in mice. | 2 |
| 20 | 20 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.